Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T49072 | ||||
Target Name | Urotensin II receptor (UTS2R) | ||||
Type of Target |
Clinical trial |
||||
Drug Potency against Target | Ac-FWKY-NH2 | Drug Info | Ki < 10000 nM | [4] | |
Ac-SFWKYS-NH2 | Drug Info | Ki < 10000 nM | [4] | ||
Ac-WKY-NH2 | Drug Info | Ki < 10000 nM | [4] | ||
Ac-[CFWKFC]-NH2 | Drug Info | Ki = 17 nM | [4] | ||
AGTAD[CFWKYC]V | Drug Info | Ki = 0.19 nM | [4] | ||
ICI-199441 | Drug Info | Ki = 4000 nM | [1] | ||
JNJ-28318706 | Drug Info | IC50 = 84 nM | [3] | ||
PALOSURAN | Drug Info | IC50 = 17 nM | [4] | ||
SB-328872 | Drug Info | Ki = 110 nM | [2] | ||
SB-436811 | Drug Info | Ki = 3.2 nM | [4] | ||
References | |||||
REF 1 | Potent and selective small-molecule human urotensin-II antagonists with improved pharmacokinetic profiles. Bioorg Med Chem Lett. 2008 Jul 1;18(13):3716-9. | ||||
REF 2 | Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3950-4. | ||||
REF 3 | Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits. J Med Chem. 2009 Dec 10;52(23):7432-45. | ||||
REF 4 | Urotensin-II receptor modulators as potential drugs. J Med Chem. 2010 Apr 8;53(7):2695-708. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.